← Back to Search

Behavioral Intervention

ACT for Infertility

N/A

Recruiting

Led By Rhonda Merwin, PhD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients must be at least 18 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up gad-2: weeks 2 (session 2), 3 (session 3), 4 (session 4), 5 (session 5), 7 (session 7), 8 (session 8), 9 (session 9), 10 (session 10), and 11 (session 11).

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if Acceptance and Commitment Therapy (ACT) can help infertility patients experiencing distress. Up to 10 patients will receive 12 therapy sessions. The study will look at how

Who is the study for?

This trial is for up to 10 individuals experiencing infertility and related psychological distress, such as depression or anxiety. Participants will engage in a therapy program called Acceptance and Commitment Therapy (ACT) for 12 sessions to see if it helps improve their emotional well-being.

What is being tested?

The study tests the effectiveness of Acceptance and Commitment Therapy (ACT), which includes 12 therapy sessions aimed at reducing psychological distress in people dealing with infertility. The goal is to assess whether ACT can enhance mood, reduce stress, and increase psychological flexibility.

What are the potential side effects?

As this trial involves psychological therapy rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort or increased awareness of distressing thoughts during the process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ phq-2: weeks 2 (session 2), 3 (session 3), 4 (session 4), 5 (session 5), 7 (session 7), 8 (session 8), 9 (session 9), 10 (session 10), and 11 (session 11).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~phq-2: weeks 2 (session 2), 3 (session 3), 4 (session 4), 5 (session 5), 7 (session 7), 8 (session 8), 9 (session 9), 10 (session 10), and 11 (session 11).

This trial's timeline: 3 weeks for screening, Varies for treatment, and phq-2: weeks 2 (session 2), 3 (session 3), 4 (session 4), 5 (session 5), 7 (session 7), 8 (session 8), 9 (session 9), 10 (session 10), and 11 (session 11). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of the Intervention

Secondary study objectives

Change in Comprehensive Assessment of Acceptance and Commitment Therapy (CompACT-15)

Change in Fertility Problem Inventory (FPI)

Change in Generalized Anxiety Disorder Questionnaire 2 (GAD-2)

+7 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Acceptance and Commitment TherapyExperimental Treatment1 Intervention

For those that enroll in the study, the therapist will see patients for 12 therapy sessions in the fertility clinic, with sessions lasting between 50 and 60 minutes. The therapist will offer both in-person and virtual sessions.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Acceptance and Commitment Therapy

2010

Completed Phase 1

~1490

0 / 1Eligibility criteria met